Abstract
Supplementary Material for: Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have